LEXINGTON, Mass.--(BUSINESS WIRE)--Aug. 6, 2012-- Synta Pharmaceuticals Corp. (NASDAQ: SNTA) today announced that the Company will be presenting at the following upcoming investor conferences:

Wedbush PacGrow Lifesciences Management Access Conference in New York
Tuesday, August 14 at 3:05 p.m. (ET)

Canaccord Genuity 32nd Annual Growth Conference in Boston
Thursday, August 16 at 9:00 a.m. (ET)

A live audio webcast and replay of both presentations will be available on the "Investors" section of the Company's website, www.syntapharma.com.

About Synta Pharmaceuticals

Synta Pharmaceuticals Corp. is a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to extend and enhance the lives of patients with severe medical conditions, including cancer and chronic inflammatory diseases. Synta has a unique chemical compound library, an integrated discovery engine, and a diverse pipeline of clinical- and preclinical-stage drug candidates with distinct mechanisms of action and novel chemical structures. All Synta drug candidates were invented by Synta scientists using our compound library and discovery capabilities. For more information, please visit www.syntapharma.com.

Source: Synta Pharmaceuticals Corp.

Synta Pharmaceuticals Corp.
George Farmer, 781-541-7125